Charles River Laboratories | CRL - Заемный капитал

Биржевая цена
165.78
Изменение за день
-1.19 -0.71%
Ежемесячно
-4.66%
Ежегодный
39.95%
Q2 прогноз
166.17




Заемный капитал Изменить Дата
Agilent USD 3.05B 0 2025-12
Align Technology USD 0 0 2024-12
Bio-Rad Laboratories USD 802.9M 398.8M 2026-03
Bruker USD 1.85B 131.7M 2025-12
Cardinal Health USD 8.25B 102M 2026-03
Charles River Laboratories USD 2.14B 49.09M 2025-12
Cigna USD 29.37B 1.5B 2026-03
Concord Medical Services Hldg CNY 2.27B 3.79M 2025-06
CVS Health USD 60.5B 6M 2025-12
Danaher USD 17.56B 855M 2026-03
Dentsply International USD 2.02B 2M 2025-12
Elevance Health USD 30.77B 29M 2026-03
Galapagos EUR 5.19M 574K 2025-12
Humana USD 12.27B 95M 2026-03
Illumina USD 1.49B 0 2026-03
Incyte USD 29.41M 785K 2026-03
Intrexon USD 0 198.67M 2024-06
IQVIA Holdings USD 13.88B 1.09B 2025-12
Laboratory Of America USD 5.9B 748.3M 2026-03
Lonza CHF 3.88B 323M 2025-12
McKesson USD 5.43B 586M 2025-12
Merck EUR 10.73B 277M 2025-12
Mettler Toledo International USD 2.09B 58.01M 2025-12
Novartis USD 29.59B 5.35B 2025-12
Pfizer USD 57.41B 93M 2025-09
Quest Diagnostics USD 5.16B 12M 2026-03
Revvity USD 2.63B 543K 2025-12
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
United Therapeutics USD 100M 100M 2024-06
UnitedHealth USD 71.44B 880M 2026-03
Veradigm USD 200.4M 69K 2022-12
Waters USD 1.41B 460.24M 2025-12
West Pharmaceutical Services USD 202.8M 0 2026-03